GALECTIN THERAPEUTICS INC. Temporary Equity, Redemption Value (Deprecated 2014-01-31)
GALECTIN THERAPEUTICS INC. (GALT) had Temporary Equity, Redemption Value (Deprecated 2014-01-31) of $241.00 thousand as of 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Notes
us-gaap:TemporaryEquityRedemptionValue · last filed 2013-11-12
- 2013-09-30: Temporary Equity, Redemption Value (Deprecated 2014-01-31) $241.00K.
- 2013-06-30: Temporary Equity, Redemption Value (Deprecated 2014-01-31) $241.00K.
| Period end | Temporary Equity, Redemption Value (Deprecated 2014-01-31) |
|---|---|
| 2013-09-30 | $241.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $241.00K 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |